Image

Global Insulin Delivery Devices Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 50
  • No of Figures: 250
  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 50
  • No of Figures: 250

Global Insulin Delivery Devices Market, By Product Type (Insulin Pens, Insulin Pumps, Pen Needles, Insulin Syringes, Insulin Injectors, Others), Application (Type I Diabetes, Type II Diabetes), End User (Hospitals and Clinics, Homecare, Specialty Centers), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/Centers) – Industry Trends and Forecast to 2029

Insulin Delivery Devices Market

Global Insulin Delivery Devices Market Analysis and Size

Insulin refers to a blood-sugar regulating hormone that plays a crucial role in the treatment of diabetes. Individuals who are suffering from diabetes use one of the available insulin delivery devices for accessing an insulin dose. The rise in awareness regarding diabetes is escalating the growth of insulin delivery devices market.

  • It is an essential part of the treatment plan for patients with T1DM and advanced type 2 diabetes mellitus (T2DM). Global Insulin Delivery Devices Market was valued at USD 12.51 billion in 2021 and is expected to reach USD 28.54 billion by 2029, registering a CAGR of 7.90% during the forecast period of 2022-2029.

Global Insulin Delivery Devices Market Definition

The consumption of insulin is not possible in the form of a tablet or a swallowed in liquid form, as it tends to get degenerated by digestive enzymes and juices when it reaches bloodstream. Thus, the infusion or injection is usually processed into the fatty tissue. Wide range of devices are used to deliver insulin to the target location, including insulin pumps, jet injectors, syringes and jet injectors. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Insulin Pens, Insulin Pumps, Pen Needles, Insulin Syringes, Insulin Injectors, Others), Application (Type I Diabetes, Type II Diabetes), End User (Hospitals and Clinics, Homecare, Specialty Centers), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/Centers)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

BD (US), Medtronic (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), Lily. (US), YPSOMED (Switzerland), Novo Nordisk A/S (Denmark), Beta Bionics, Inc. (US), Owen Mumford Ltd. (UK), Sanofi (France), B. Braun Melsungen AG (Germany), Abbott (US), Tandem Diabetes Care, Inc. (US), Copernicus (Poland), Insulet Corporation (US), West Pharmaceutical Services, Inc. (US), InsuJet (Netherlands), SHL Medical AG (Switzerland), SOOIL Developments Co., Ltd. (South Korea), and Johnson & Johnson Services, Inc. (US), among others

Insulin Delivery Devices Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

  • Diabetic Population

The increase in the number of people suffering from diabetes across the globe acts as one of the major factors driving the growth of insulin delivery devices market.

  • Favorable Reimbursement Scenario

The presence of favorable reimbursement environment and government support in selected countries accelerate the market.

  • Surge in Health Expenditure

The surge in the diabetes-related health expenditure in emerging economies further influence the insulin delivery devices market.

  • Awareness about Insulin Delivery Devices

The increase in the conferences, meetings, and congresses for rising awareness about insulin delivery devices will assist in the expansion of the market.

Opportunities

Furthermore, rise in research and development activities extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, technological advancements in insulin delivery devices will assist in the expansion of the market.

Restraints/Challenges Global Insulin Delivery Devices Market

On the other hand, issues associated with the reuse of pen needles and infusion sets and poor reimbursement structure in developing countries are expected to obstruct market growth. Also, needle anxiety in patients and oral insulin as an alternative drug delivery method are projected to challenge the insulin delivery devices market in the forecast period of 2022-2029.

This insulin delivery devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on insulin delivery devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Insulin Delivery Devices Market

The COVID-19 pandemic had a big impact on the insulin delivery devices market both, positively ane negatively. Major medical procedures were declined during the pandemic in order to prevent the risk of spreading coronavirus. However, healthcare organizations were preparing new plans to respond growing COVID-19 patients, such as sourcing rapid diagnosing kits to sufficient PPE kits for workers. Diabetic populace had to take extra precautions as they are at higher risk of acquiring an infection. The market was not affected harshly as insulin injection is essential for patients suffering from diabetes.

Recent Development

  • The Brazilian National Health Surveillance Agency (ANVISA) gave registration certificates insulin glargine injection and insulin glargine injection (prefilled pen) by Gan & Lee in 2020. the first shipments of these insulin injections were successfully delivered to Brazil in the early of 2021.

Global Insulin Delivery Devices Market Scope and Market Size

The insulin delivery devices market is segmented on the basis of product type, application, end user and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Insulin Pens
  • Insulin Pumps
  • Pen Needles
  • Insulin Syringes
  • Insulin Injectors
  • Others

On the basis of product type, the insulin delivery devices market is segmented into insulin pens, insulin pumps, pen needles, insulin syringes, insulin injectors and others. Insulin pens have further been segmented into reusable insulin pens and disposable insulin pens. Insulin pumps have further been segmented into external/tethered pumps and patch pumps. Pen needles have further been segmented into standard pen needles and safety pen needles.

Application

  • Type I Diabetes
  • Type II Diabetes

The insulin delivery devices market can is segmented on the basis of application into type I diabetes and type II diabetes.

End User

  • Hospitals and Clinics
  • Homecare
  • Specialty Centers

The end user segment of the insulin delivery devices market is segmented into hospitals and clinics, homecare and specialty centers.

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales
  • Diabetes Clinics/Centers

Based on distribution channel, the insulin delivery devices market is segmented into hospital pharmacy, retail pharmacy, online sales and diabetes clinics/centers.

Insulin Delivery Devices Market Regional Analysis/Insights

The insulin delivery devices market is analysed and market size insights and trends are provided by country, product type, application, end user and distribution channel as referenced above.

The countries covered in the insulin delivery devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the insulin delivery devices market because of the prevalence of diabetes and favorable reimbursement scenario within the region.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rise in patient awareness toward disease in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The insulin delivery devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for insulin delivery devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the insulin delivery devices market. The data is available for historic period 2010-2020.

Competitive Landscape and Insulin Delivery Devices Market Share Analysis

The insulin delivery devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to insulin delivery devices market.

Some of the major players operating in the insulin delivery devices market are BD (US), Medtronic (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), Lily. (US), YPSOMED (Switzerland), Novo Nordisk A/S (Denmark), Beta Bionics, Inc. (US), Owen Mumford Ltd. (UK), Sanofi (France), B. Braun Melsungen AG (Germany), Abbott (US), Tandem Diabetes Care, Inc. (US), Copernicus (Poland), Insulet Corporation (US), West Pharmaceutical Services, Inc. (US), InsuJet (Netherlands), SHL Medical AG (Switzerland), SOOIL Developments Co., Ltd. (South Korea), and Johnson & Johnson Services, Inc. (US), among others.

Research Methodology : Global Insulin Delivery Devices Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-insulin-delivery-devices-market


SKU-
Why Choose Us


Frequently Asked Questions

The Insulin Delivery Devices Market was Valued at USD 12.51 Billion in 2021.
The Insulin Delivery Devices Market is Expected to Witness CAGR of 7.90% During the Forecast Period of 2022 to 2029.
Some of the Major Players Operating in the Insulin Delivery Devices Market are BD (US), Medtronic (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), Lily. (US), YPSOMED (Switzerland), Novo Nordisk A/S (Denmark), Beta Bionics, Inc. (US), Owen Mumford Ltd. (UK), Sanofi (France), B. Braun Melsungen AG (Germany), and Abbott (US), among others.
The Countries Covered in the Insulin Delivery Devices Market Report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Insulin Delivery Devices Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.